ProCE Banner Events


2023 PCE Oncology Spring Conferences – Solid Tumors

PCE, the national leader in continuing education for NPs and PAs, returns this April with our virtual Spring Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Live streamed for your convenience and to allow access nationwide. Register now!

Physician Assistants/Physician Associates: 6.00 AAPA Category 1 CME credits

Nurse Practitioners: 6.00 Nursing contact hours, includes 6.00 hours of pharmacotherapy credit.

This event has expired. No longer available for credits.

Credits Available

Attendees can earn 6.0 CE/CME credits, including pharmacology credit for NPs.

Who Should Attend

Oncology NPs, PAs, and RNs

Time and location

Saturday, April 22, 2023

9:00 AM - 4:20 PM Eastern Time (ET)


Jeremy M. Force, DO

Assistant Professor
Department of Medicine
Division of Medical Oncology
Breast Oncology Program
Duke University
Durham, North Carolina

Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

Robert Lentz, MD

Assistant Professor of Medicine
Department of Medicine
Division of Medical Oncology
University of Colorado School of Medicine and Cancer Center
Aurora, Colorado

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

Frank dela Rama, RN, MS, AOCNS, AGN-BC

Clinical Nurse Specialist, Oncology/Geonomics
Palo Alto Medical Foundation
Sutter Health
Palo Alto, California 

Megan Schollenberger, MSN, CRNP

Senior Nurse Practitioner
Melanoma and Cancer Immunology Programs
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Baltimore, Maryland

Terran W. Sims, MSN, ACNP-C, CNN-BC, COCN

Nurse Practitioner
Department of Urology
University of Virginia
Charlottesville, Virginia


8:30 AM – 9:00 AM ET Log-in

9:00 AM – 10:00 AM ET Non-accredited Presentation Theater: IMFINZI® (durvalumab) in Combination With IMJUDO® (tremelimumab-actl) for the First-line Treatment of Unresectable Hepatocellular Carcinoma
Katie Green, MSN, CRNP

10:00 AM – 10:05 AM ET Welcome and Opening Remarks
Terran W. Sims MSN, ACNP-C, CNN, COCN-C

10:05 AM – 11:05 AM ET Advancing Care and Improving Survival for Patients With HER2-Positive Breast Cancer
Jeremy M. Force, DO

11:05 PM – 12:05 PM ET Applying Novel Strategies to the Treatment of Advanced Renal Cell Carcinoma
Mary Dunn, MSN, NP-C, OCN, RN

12:05 PM – 1:05 PM ET Sorting Through the Complexities of Managing Metastatic Colorectal Cancer: Strategies for Individualizing Treatment
Robert J. Lentz, MD

1:05 PM – 1:15 PM ET Break

1:15 PM – 2:15 PM ET PARP Inhibitors in Prostate Cancer: Improving Patient Outcomes Through Precision Therapy
Frank dela Rama, RN, MS, AOCNS, AGN-BC

2:15 PM  – 3:15 PM ET An Update on Biomarkers in NSCLC Clinical Management
Rasheda Persinger, MSN, AGNP-C, AOCNP

3:15 PM – 4:15 PM ET Melanoma Moments: Expert Insight Into Current Treatment Paradigms and the Latest Advances in Melanoma
Megan D. Schollenberger, NP

4:15 PM – 4:20 PM ET Summary and Closing Remarks
Terran W. Sims MSN, ACNP-C, CNN, COCN-C


Target Audience
Oncology NPs, PAs, and RNs

Learning Objectives:

  • Summarize current recommendations for biomarker testing for patients with different cancers
  • Identify novel treatment strategies appropriate for individual patients based on patient- and disease-related characteristics
  • Implement strategies to recognize and manage treatment-related AEs and support/improve treatment adherence


Per Topic

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

AAPA Credit Designation

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation


This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Supported by educational grants from AstraZeneca, Exelixis, Inc., Merck Sharp & Dohme LLC., Novartis Pharmaceuticals Corporation, and Seagen.

Contact Information

Contact Clinical Care Options

For customer support please email:

Mailing Address:

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act  - N/A virtual only
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact prior to the live event.